GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
Clinical trial NCT03821129 · RECRUITING
Trial details
- NCT number
- NCT03821129
- Sponsor
- W.L.Gore & Associates
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-25
- Primary completion
- 2028-10-01
- Enrollment
- 636
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.